Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Frank Milton Balis, M.D.

Frank Milton Balis, M.D.

faculty photo
Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
3501 Civic Center Blvd., Room CTRB4024
Philadelphia, PA 19104
Office: 267-426-5414
Fax: 267-425-0113
B.S. (Zoology)
University of North Carolina, 1971.
M.D. (Medicine)
Vanderbilt University, 1975.
Permanent link
Perelman School of Medicine > Faculty > Search

Description of Clinical Expertise

Solid tumors in children, renal tumors in children, clinical pharmacology of anticancer drugs

Description of Research Expertise

Clinical pharmacology of anticancer drugs

Selected Publications

Fox Elizabeth, Widemann Brigitte C, Chuk Meredith K, Marcus Leigh, Aikin Alberta, Whitcomb Patricia O, Merino Maria J, Lodish Maya, Dombi Eva, Steinberg Seth M, Wells Samuel A, Balis Frank M: Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma. Clin Cancer Res 19(15): 4239-48, Aug 2013.

Mossé Yael P, Lim Megan S, Voss Stephan D, Wilner Keith, Ruffner Katherine, Laliberte Julie, Rolland Delphine, Balis Frank M, Maris John M, Weigel Brenda J, Ingle Ashish M, Ahern Charlotte, Adamson Peter C, Blaney Susan M: Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol 14(6): 472-80, May 2013.

Widemann BC, Kim A, Fox E, Baruchel S, Adamson PC, Ingle AM, Glade-Bender J, Burke M, Weigel B, Stempak D, Balis FM Blaney SM.: A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report. Clin Cancer Res 18(21): 6011-22, 2013.

Kim A, Dombi E, Tepas K, Fox E, Martin S, Wolters P, Balis FM, Jayaprakash N, Turkbey B, Muradyan N, Choyke PL, Korf B, Widemann BC. : Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas. Pediatr Blood Cancer 60(3): 396-401, 2013.

Warren KE, Gururangan S, Geyer JR, McLendon RE, Poussaint TY, Wallace D, Balis FM, Berg SL, Packer RJ, Goldman S, Minturn JE, Pollack IF, Boyett JM, Kun LE.: A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high grade gliomas and brainstem gliomas: A Pediatric Brain Tumor Consortium Study. J Neuro-Oncol 106: 643-9, 2012.

Lodish M, Dagalakis U, Chen C, Sinaii N, Whitcomb T, Aikin A, Dombi E, Marcus L, Widemann B, Fox E, Chuk M, Balis FM, Wells S, Jr, Stratakis CA. : 111 In-Octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents. J Clin Endocrinol Metab 97: E207-12, 2012.

Murphy RF, Komlodi-Pasztor E, Robey R, Balis FM, Farrell NP, Fojo T. : Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum resistant cells compared to cisplatin and oxaliplatin. Cell Cycle 11: 963-73, 2012.

Chuk MK, Aikin A, Whitcomb T, Widemann BC, Zannikos P, Beyever E, Balis FM, Fox E. : A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors. Pediatr Blood Cancer 59: 865-9, 2012.

Kim A, McCully C, Cruz R, Cole DE, Fox E, Balis FM, Widemann BC. : The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates. Invest New Drugs 30: 524-8, 2012.

Balis FM, Fox E. : Challenges of developing new drugs for childhood cancers. Clin Investig 2: 291-300, 2012.

back to top
Last updated: 09/05/2013
The Trustees of the University of Pennsylvania